JAK2 and gastric cancer: Some studies have demonstrated that the Janus-activated kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway are correlated with tumor progression, such as gastric cancer [14], colorectal cancer [15], and hepatocellular carcinoma [16].